SCHEMBL19009043

SCHEMBL19009043

CN1C(=O)c2cc(Cl)c3c4c(cc(Cl)c(c24)C1=O)C(=O)N(C)C3=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
KDM4E B2RXH2 1/20 0.44
NQO2 P16083 3/20 0.38
CASP3 P42574 1/20 0.36
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
USP2 O75604 2/20 0.35
CASP1 P29466 1/20 0.35
BRCA1 P38398 1/20 0.35
CASP7 P55210 1/20 0.35
MAPT P10636 3/20 0.34
HSD17B10 Q99714 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
LMNA P02545 1/20 0.34
PABPC1 P11940 1/20 0.34
ALOX15 P16050 1/20 0.34
CA9 Q16790 2/20 0.33
APP P05067 2/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19009047 0.94 ALDH1A1 (0.43) ALDH1A1HPGDKDM4ENQO2CASP3
SCHEMBL12744258 0.81 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ENQO2CASP3
SCHEMBL9525319 0.80 ALDH1A1 (0.47) ALDH1A1HPGDKDM4ECASP3MEN1
SCHEMBL8730344 0.79 ALDH1A1 (0.38) ALDH1A1HPGDKDM4ENQO2CASP3
SCHEMBL9485161 0.78 ALDH1A1 (0.40) ALDH1A1HPGDKDM4ECASP3MEN1
SCHEMBL10001318 0.77 APP (0.38) ALDH1A1HPGDKDM4ECASP3MEN1
SCHEMBL12869404 0.75 MEN1 (0.37) ALDH1A1HPGDKDM4ECASP3MEN1
SCHEMBL12107460 0.75 APP (0.39) ALDH1A1HPGDKDM4ECASP3MEN1
SCHEMBL13589567 0.75 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL17303441 0.75 ALDH1A1 (0.38) ALDH1A1HPGDKDM4ENQO2CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3183250-B1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL CLAP CO LTD (KR) 2023-10-04 EP disclosed
US-20170174676-A1 CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2017-06-22 US disclosed
US-20170174676-A1 CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174676-A1 CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS SLCO2A1, SLCO2B1, SLC43A3 ALDH1A1 1455/4885HPGD 841/4885KDM4E 4317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.